American Journal of Cardiovascular Drugs

Ambrisentan
pp. 215-226(12)
Author: Frampton, James E.

Fenofibrate: A Review of its Lipid-Modifying Effects in Dyslipidemia and its Vascular Effects in Type 2 Diabetes Mellitus
pp. 227-247(21)
Author: Keating, Gillian M.

Fimasartan
pp. 249-252(4)

Attenuation of Rate of Change in Carotid Intima-Media Thickness by Lipid-Modifying Drugs: Impact on Clinical Outcomes
pp. 253-263(11)
Authors: Peters, Sanne A.E.; Ruijter, Hester M. den; Bots, Michiel L.

Role of Emerging Antithrombotic Therapy in the Prevention of Cardioembolic Complications in Patients with Atrial Fibrillation
pp. 265-275(11)
Authors: Deedwania, Prakash C.; Huang, Grace W.

Role of Irbesartan in Prevention of Post-Coronary Artery Bypass Graft Atrial Fibrillation
pp. 277-284(8)
Authors: El-Haddad, Mohamed A.; Zalawadiya, Sandip K.; Awdallah, Hany; Sabet, Sameh; El-Haddad, Haitham A.; Mostafa, Ashraf; Rashed, Ahmed; El-Naggar, Wael; Farag, Nabil; Saleb, Mohamed A.; Jacob, Sony

The Correct Administration of Antihypertensive Drugs According to the Principles of Clinical Pharmacology
pp. 285-285(1)
Author: Samson, Suresh

The Authors' Reply
pp. 285-285(1)
Authors: Taddei, S.; Bruno, R.M.; Ghiadoni, L.